BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28410586)

  • 1. Efficacy and safety of Jianzhong decoction in treating peptic ulcers: a meta-analysis of 58 randomised controlled trials with 5192 patients.
    Sun Y; Zhang J; Chen Y
    BMC Complement Altern Med; 2017 Apr; 17(1):215. PubMed ID: 28410586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.
    Ford AC; Gurusamy KS; Delaney B; Forman D; Moayyedi P
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003840. PubMed ID: 27092708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.
    Ford A; Delaney B; Forman D; Moayyedi P
    Cochrane Database Syst Rev; 2003; (4):CD003840. PubMed ID: 14583996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.
    Ford AC; Delaney BC; Forman D; Moayyedi P
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003840. PubMed ID: 16625592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.
    Ford A; Delaney B; Forman D; Moayyedi P
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003840. PubMed ID: 15495066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of seven Chinese patent medicines combined with conventional triple/quadruple therapy for
    Jiang Z; Deng B; Zhang Y; Li Y; Yu Z; Deng H; Chen Y
    BMJ Open; 2024 Apr; 14(4):e074188. PubMed ID: 38684278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allicin as add-on therapy for
    Si XB; Zhang XM; Wang S; Lan Y; Zhang S; Huo LY
    World J Gastroenterol; 2019 Oct; 25(39):6025-6040. PubMed ID: 31660038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.
    Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA
    Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori?
    Chan FK; Sung JJ; Lee YT; Leung WK; Chan LY; Yung MY; Chung SC
    Am J Gastroenterol; 1997 Mar; 92(3):442-5. PubMed ID: 9068465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Chinese Herbal Medicines on Helicobacter pylori-associated gastroduodenal ulcers: a systematic review and Meta-analysis.
    Shi X; Li X; Tang X; Shi X; Ma X; Yin X; Ma J; Wang F; Tang X; Wu H
    J Tradit Chin Med; 2019 Aug; 39(4):459-465. PubMed ID: 32186092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease.
    Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K; Okada H; Shiratori Y
    Am J Gastroenterol; 2005 May; 100(5):1037-42. PubMed ID: 15842576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection.
    Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
    World J Gastroenterol; 2015 Apr; 21(16):4954-60. PubMed ID: 25945009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of Helicobacter pylori infection in patients with peptic ulcer perforation.
    Andreson H; Sillakivi T; Peetsalu M; Peetsalu A; Mikelsaar M
    Scand J Gastroenterol; 2007 Mar; 42(3):324-9. PubMed ID: 17354111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter evaluation of dual-therapy (omeprazol and amoxycillin) for Helicobacter pylori-associated duodenal and gastric ulcer (two years of the observation).
    Gabryelewicz A; Laszewicz W; Dzieniszewski J; Ciok J; Marlicz K; Bielecki D; Popiela T; Legutko J; Knapik Z; Poniewierka E
    J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():93-105. PubMed ID: 9440060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.
    Gisbert JP; Khorrami S; Carballo F; Calvet X; Gene E; Dominguez-Muñoz E
    Aliment Pharmacol Ther; 2004 Mar; 19(6):617-29. PubMed ID: 15023164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
    Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
    Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Helicobacter pylori and chronic ulcer disease].
    Gustavsson S; Engstrand L
    Lakartidningen; 1991 Feb; 88(8):624-5. PubMed ID: 2002726
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer.
    Nebiki H; Higuchi K; Arakawa T; Ando K; Uchida T; Ito H; Harihara S; Kuroki T; Kobayashi K
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):203S-206S. PubMed ID: 9753251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent studies on therapy of peptic ulcers].
    Asaka M
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1750-4. PubMed ID: 10581758
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.